Abstract
For this lively and informative session, the affirmative argument was taken by Assistant Professor Parambir Dulai, and the negative by Dr Nick Kennedy. A summary of the key points from each presenter’s arguments are presented.
| Original language | English |
|---|---|
| Pages (from-to) | 25-26 |
| Number of pages | 2 |
| Journal | Journal of Gastroenterology and Hepatology (Australia) |
| Volume | 36 |
| Issue number | S1 |
| DOIs | |
| Publication status | Published - Apr 2021 |
| Event | IBD 2020: Right therapy, right patient, right time#Choosing wisely: Proceedings of the Takeda IBD Symposium - Virtual Duration: 5 Sept 2020 → 9 Sept 2020 |
Bibliographical note
Funding Information:Funded through an unrestricted educational grant from Takeda Pharmaceuticals Pty Ltd.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- anti-tumor necrosis factors
- TNF
- inflammatory bowel disease (IBD)
Fingerprint
Dive into the research topics of 'Anti-tumor necrosis factors (TNFs) are outdated—It's time to move on: Session three summary'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver